@prefix : <http://semanticscholar.org/cv-research/> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix fhir_link: <http://hl7.org/fhir/link/> .
@prefix ncit: <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sso: <http://semanticscholar.org/cv-research/> .
@prefix whocv: <http://semanticscholar.org/cv-research/WHO#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://fhircat.org/cord-19/metadata/f98ea77d586b02146fe03a209e44a0c1e8883ea5> fhir_link: <https://fhircat.org/cord-19/fhir/Non-comercial/f98ea77d586b02146fe03a209e44a0c1e8883ea5> ;
    dc:abstract "Hepatitis E virus (HEV) is one of the leading causes of acute viral hepatitis. It also causes acute liver failure and acute-on-chronic liver failure in many patients, such as those suffering from other infections/liver injuries or organ transplant/chemotherapy recipients. Despite widespread sporadic and epidemic incidents, there is no specific treatment against HEV, justifying an urgent need for developing a potent antiviral against it. This review summarizes the known antiviral candidates and provides an overview of the potential targets for the development of specific antivirals against HEV." ;
    dc:creator "['Anang, Saumya', 'Kaushik, Nidhi', 'Surjit, Milan']" ;
    dc:identifier <http://dx.doi.org/10.14218/JCTH.2018.00005>,
        <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160310>,
        <https://www.ncbi.nlm.nih.gov/pubmed/30271744> ;
    dc:issued "2018-01-01"^^xsd:date ;
    dc:license "CC BY-NC" ;
    dc:title "Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus" ;
    sso:has_full_text "True" ;
    sso:journal "J Clin Transl Hepatol" ;
    sso:sha "f98ea77d586b02146fe03a209e44a0c1e8883ea5" ;
    sso:source_x "PMC" .